Browse Biological products industry topic

Forecasts and trends subtopic

Articles 1-27 out of 27 article(s) Title Author Type Date Words Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics. Industry overview Nov 10, 2009 609 Reportlinker Adds Autoimmune Disease Therapeutics. Jul 16, 2009 3090 Research and Markets: Biopharma Quarter - Key Trends and Events of the First Quarter of 2009. Jul 15, 2009 438 Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015. Jun 4, 2009 3085 Reportlinker Adds Global Dental Devices Investment Opportunities, Analysis and Forecasts to 2015. Jun 2, 2009 4645 Reportlinker Adds Global Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015. May 27, 2009 4794 Reportlinker Adds World Monoclonal Antibody Based Products Market Report. Mar 19, 2009 5219 High Growth Forecasted for the China Vaccine Market Report, 2007-2009. Report Dec 11, 2008 1690 Zacks Bull and Bear of the Day Highlights: Genentech, Salix Pharmaceuticals, CACI International, Consolidated Edison and Align Technology. Apr 15, 2008 996 Research and Markets: a Full Review of Gilead Sciences Company's Activities Together with Five-Year Sales Forecasts. Aug 2, 2007 504 Learn about the Top 20 Cancer Therapy Brands - Sales of Targeted Therapies Overtake Cytotoxics in 2006. Jul 24, 2007 1109 In The Aftermath Of Medimmune v. Genentech, Is It All Doom And Gloom For Licensors Or Are There Rays Of Hope In The Future? Jul 8, 2007 3370 Research & Markets: Gilead Sciences Acquisitions of Myogen and Corus Pharma Has Significantly Expanded the Scope of Their Research Efforts. Apr 19, 2007 522 Zacks Analyst Blog Highlights: Gilead Sciences, GlaxoSmithKline, Snap-on and Grey Wolf. Feb 5, 2007 785 Research and Markets: A Fourth Division for Novartis under the Title Vaccines & Diagnostics, Will Be Created After the Acquisition of Chiron Corporation. Sep 1, 2006 430 Dutton Associates Announces Investment Opinion: MorphoSys AG Strong Speculative Buy Rating in Update Coverage by Dutton Associates. Aug 21, 2006 493 Schaeffer's S&P 500 Index Hot Stocks Features Millipore, Serologicals, E. W. Scripps, Yum! Brands, and Coach. Apr 25, 2006 855 Serologicals to acquire assay maker LINCO. Mar 31, 2006 152 Schaeffer's Midday Options Update Features AT&T, Ruby Tuesday, GlaxoSmithKline, AVI BioPharma, and Lamson & Sessions. Mar 30, 2006 1262 In the Therapeutic Vaccine Industry, Cancer Vaccines Accounted for 60.6% of Projects Being Developed. Feb 14, 2006 370 Understand how Chirons Problems with Vaccines Manufacturing Has Affected its Position within the Global Market. Nov 30, 2005 125 CEO INTERVIEW: RON LIPSTEIN - ORTEC INTERNATIONAL INC (ORTN). Brief Article Jul 28, 2003 89 CEO INTERVIEW: ALEX MCPHERSON - BIOMIRA INC (BIOM). Brief Article Jul 28, 2003 88 CEO INTERVIEW: MARTIN MCGLYNN - STEMCELLS INC (STEM). Brief Article Jul 28, 2003 88 Industry Maintaining Its Growth but Economic Slowdown May Prevent Tech Transfer From Reaching Full Potential. DARMIENTO, LAURENCE Brief Article Dec 25, 2000 885 DNA Chip Technology: A Promising Future for Diagnosing Disease. WEBB, MARION Company Profile Jul 3, 2000 1420 Spinal Markets To Grow at 7 Percent Rate, Top $300 Million, Slowed By Regulatory, Legal Worries. Jan 2, 1996 517